AGTC Establishes New Office Facility in Cambridge, Massachusetts
September 02, 2015 07:37 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...
AGTC Announces Achievement of XLRS Patient Enrollment Milestone in Biogen Collaboration
August 27, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Aug. 27, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...
AGTC Announces Strategic Collaboration With Biogen Effective and Biogen Equity Investment Closed
August 19, 2015 16:05 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...
AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 12, 2015
August 03, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC President & CEO to Present at Cantor Healthcare Conference on July 8, 2015
July 06, 2015 09:16 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., July 6, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC to Host Conference Call and Webcast to Discuss Biogen Collaboration
July 02, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., July 2, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC to Host Analyst and Investor Day on June 22, 2015 in New York
June 15, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., June 15, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Appoints Mark S. Shearman Chief Scientific Officer
June 01, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., June 1, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Appoints Rabia Ozden as Vice President of Clinical Research and Development
June 01, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., June 1, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Announces New Data Supporting Novel Gene-Based Therapies for Rare Inherited Retinal Diseases
May 18, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
NEW ORLEANS, May 18, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...